The Fall 2017 issue of The Visionary is now available! The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research, and global efforts focused on improving eye cancer treatment, diagnosis, and cure. In this edition, you will find articles about: Details regarding the highly anticipated Second Eye Cancer Working Day and its [..] Read More…
After two successful meetings where eye cancer patients and survivors shared their feelings in a welcoming, comfortable environment, The New York Eye Cancer Center Support Group, sponsored by The Eye Cancer Foundation, will meet for a third time on November 17, 2017 at 1:30 PM, Eastern Standard Time. This meeting, like its previous ones, will [..] Read More…
The New York Eye Cancer Center Support Group, sponsored by the Eye Cancer Foundation, met for the second time on October 13, 2017. Members in attendance were in varying stages of their treatment and recovery, ranging from a few months to over a decade! Karen Campbell, a licensed clinical social worker with years of experience [..] Read More…
As the year draws to close, as we round out the end of 2017 with holidays celebrating unity, generosity and love, now comes the time for reflection. The year 2017 marked great, landscaping efforts in the field of eye cancer research and training from The Eye Cancer Foundation, culminating perhaps most fantastically with the [..] Read More…
An intraocular injection (i.e., an injection made directly into the eye) may sound intimidating, uncommon, and dangerous. But did you know that intraocular injections are one of the most common surgical procedures practiced today in the United States? These injections are used mostly to treat macular degeneration, a deterioration of the sensitive, central portion of [..] Read More…
As you may have read in our blog the week prior, The New York Eye Cancer Center is pleased to announce that we, with the support of The Eye Cancer Foundation, are hosting periodic group therapy sessions for our patients. Life after diagnosis and treatment of an ocular melanoma can cause stress and anxiety. Although [..] Read More…
Eye-sparing plaque brachytherapy can now help more patients with uveal melanoma versus enucleation. The American Brachytherapy Society (ABS) reports that more patients with uveal melanoma will be able to spare their eye by widening the criteria for plaque brachytherapy. It had been 10 years since guidelines for the treatment of uveal melanoma were published — but now, [..] Read More…
Stress and anxiety following treatment for choroidal melanoma have been well recognized among patients and studied among doctors. In fact, The NIH-funded Collaborative Ocular Melanoma Study reported on 209 patients with medium-sized melanoma treated with either brachytherapy or enucleation. In this sub-study, their goal was to compare the quality of life between treatment groups using [..] Read More…
If you’ve been recently diagnosed with an eye cancer, such as ocular surface squamous neoplasia or conjunctival melanoma, it’s normal to feel a little nervous – but, there’s good news. It is possible to treat some of these cancers with topical chemotherapy eye drops, like interferon alpha (also called Intron A), instead of surgery. Interferon [..] Read More…
“Sharing a common scientific language (staging systems) allow us to communicate our ideas and enable progress” writes Dr. Paul T. Finger in Foundational Elements for Collaboration in Ophthalmic Oncology; a recent editorial published for the American Academy of Ophthalmology. Communication is vital in nearly all areas of life, and the medical field makes no exception. In [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
